Fixing the Foundations: How Pharma Can Remediate Common Data Quality Issues

This piece is one installment in our ongoing series exploring the foundations of trustworthy AI in regulated industries. To read the earlier articles, visit the series overview page: Data Quality & Culture Series.

Pharmaceutical and life sciences organizations operate in some of the most data‑intensive and highly regulated environments in the world. Yet even the most advanced companies struggle with persistent data quality issues, incomplete records, inconsistent formats, manual entry errors, fragmented systems, and missing information. These problems are not just operational annoyances; they undermine compliance, slow production, and compromise the performance of AI systems.

The good news is that most data quality issues are preventable. With the right combination of technology, governance, and cultural practices, organizations can build strong, resilient data foundations that support both regulatory requirements and digital transformation.

This article explores the most common data quality challenges in pharma and the practical remediation strategies leaders can implement to address them.

1. The Most Common Data Quality Issues in Pharma

While every organization has unique workflows and systems, several data quality issues appear consistently across the industry.

Incomplete or Inaccurate Patient Records
Clinical and safety data often contain missing values, transcription errors, or inconsistent formats. These gaps can lead to misinterpretation, delayed safety signal detection, or flawed AI models.

Inconsistent Drug Formulation Data
Manufacturing data may vary across sites or systems, with differences in units, naming conventions, or documentation practices. These inconsistencies create compliance risks and complicate AI‑driven optimization.

Delayed or Missing Pharmacovigilance Reports
Late or incomplete adverse event reporting slows the detection of safety signals and weakens the datasets used for AI‑enabled signal detection.

Fragmented Data Silos
Clinical, manufacturing, quality, and commercial teams often operate in separate systems. This fragmentation prevents holistic analysis and limits the effectiveness of AI models that require integrated datasets.

Poor Data Standardization
Without standardized formats, units, and nomenclature, data integration becomes error‑prone. AI models trained on inconsistent data produce unreliable outputs.

Manual Data Entry Errors
Human error remains one of the most persistent challenges. Studies show that manual entry contributes to a significant percentage of quality faults and product recalls.

These issues are not isolated, they compound one another. A single missing value can trigger a cascade of rework, delays, and compliance concerns.

2. Remediation Strategy #1: Automated Data Validation

Manual checks are no longer sufficient in high‑volume, high‑complexity environments. Automated validation tools can detect anomalies, flag inconsistencies, and enforce data quality rules at scale.

Benefits include:

• Reduced human error
• Faster review cycles
• Early detection of data integrity risks
• Stronger audit readiness
• Cleaner datasets for AI training

Machine‑learning‑powered validation tools can even predict where errors are most likely to occur, enabling proactive remediation.

3. Remediation Strategy #2: Standardized Data Formats and Templates

Standardization is one of the most effective ways to improve data quality. When every site, system, and team uses the same formats, units, and terminology, data becomes easier to integrate, compare, and analyze.

Standardization efforts may include:

• Enterprise‑wide data dictionaries
• Controlled vocabularies
• Harmonized units of measure
• Standard operating procedures for documentation
• Unified templates for batch records and clinical forms

Standardization reduces ambiguity and ensures that data “speaks the same language” across the organization.

4. Remediation Strategy #3: Reducing Manual Entry Through Digital Systems

Manual entry is one of the largest sources of data quality issues. Transitioning from paper‑based or hybrid systems to fully digital workflows dramatically reduces errors and strengthens traceability.

Digital transformation may include:

• Electronic batch records (EBR)
• Electronic lab notebooks (ELN)
• Digital forms with required fields
• Barcode or sensor‑based data capture
• Automated instrument integration

Organizations that adopt digital systems often see immediate improvements in accuracy, completeness, and review cycle times.

5. Remediation Strategy #4: Strengthening Data Governance

Governance provides the structure needed to maintain data quality over time. Without governance, even the best tools and processes degrade.

Effective governance includes:

• Clear ownership of data domains
• Defined roles and responsibilities
• Cross‑functional data councils
• Policies for data creation, modification, and review
• Regular audits and quality checks

Governance ensures that data quality is not a one‑time project but an ongoing discipline.

6. Remediation Strategy #5: Improving Data Lineage and Traceability

Traceability is essential for both compliance and AI. When organizations can see where data originated, how it changed, and who interacted with it, they can quickly identify and correct issues.

Lineage tools support:

• Root‑cause analysis
• Regulatory inspections
• AI model validation
• Cross‑system reconciliation
• Change management

Strong lineage practices turn data into a transparent, trustworthy asset.

7. Remediation Strategy #6: Building a Culture of Transparency and Accountability

Technology alone cannot fix data quality. A strong data culture ensures that employees feel responsible for data integrity and empowered to surface issues early.

Cultural remediation includes:

• Encouraging open reporting of anomalies
• Rewarding teams for identifying issues
• Training staff in data literacy
• Reinforcing the importance of accurate documentation
• Modeling transparency at the leadership level

Culture transforms data quality from a compliance burden into a shared organizational value.

8. Remediation Strategy #7: Continuous Monitoring and Improvement

Data quality is not static. Organizations must continuously monitor metrics, review processes, and refine standards.

Continuous improvement includes:

• Regular data quality scorecards
• Trend analysis
• Feedback loops from audits
• AI‑driven anomaly detection
• Iterative updates to standards and templates

Continuous monitoring ensures that data quality strengthens over time rather than eroding.

The Path Forward: Strong Data Foundations Enable Strong AI

Remediating data quality issues is not just about compliance, it is about building the foundation for innovation. When data is accurate, complete, consistent, reliable, and traceable, organizations can confidently scale AI, accelerate decision‑making, and improve patient outcomes.

Strong data quality is the foundation on which trustworthy AI is built.

Further Reading

For a deeper exploration of this topic, read our full white paper published on IntuitionLabs.

To see how this article fits into the broader series, view the full Data Quality & Culture Series.

Amie Harpe Founder and Principal Consultant

Amie Harpe is a strategic consultant, IT leader, and founder of Sakara Digital, with 20+ years of experience delivering global quality, compliance, and digital transformation initiatives across pharma, biotech, medical device, and consumer health. She specializes in GxP compliance, AI governance and adoption, document management systems (including Veeva QMS), program management, and operational optimization — with a proven track record of leading complex, high-impact initiatives (often with budgets exceeding $40M) and managing cross-functional, multicultural teams. Through Sakara Digital, Amie helps organizations navigate digital transformation with clarity, flexibility, and purpose, delivering senior-level fractional consulting directly to clients and through strategic partnerships with consulting firms and software providers. She currently serves as Strategic Partner to IntuitionLabs on GxP compliance and AI-enabled transformation for pharmaceutical and life sciences clients. Amie is also the founder of Peacefully Proven (peacefullyproven.com), a wellness brand focused on intentional, peaceful living.

See Full Bio